Images are for illustrative purposes only.
Bronchogen
Bronchogen is the tetrapeptide Ala-Glu-Asp-Leu (AEDL), molecular weight approximately 446 Da, originally derived from research on bovine bronchial tissue extracts. It is the respiratory-specific member of the Khavinson bioregulator series, proposed to modulate gene expression in bronchial epithelial cells.
Two peptides in the series address respiratory tissue, and they are not interchangeable. Bronchogen is a four-residue AED-family peptide focused specifically on bronchial epithelium; Chonluten (EDG) is a three-residue peptide studied across both bronchial and intestinal mucosa. Bronchogen's fourth residue, leucine, is what separates it from Epitalon (AEDG), Cardiogen (AEDR), and Cortagen (AEDP), which share its first three residues. Preclinical work from the originating group reports effects on bronchial epithelial cell viability and gene-expression markers in vitro.
Supplied as a lyophilized 10-vial 20mg kit for in vitro research use only.